HZP treatment could promote functional recovery by enhancing the expression of brain-derived neurotrophic factor (BDNF) and increasing the level of neurogenesis in cerebral ischemia-reperfusion (I/R) animal (Chen, 2010a; Zheng et al., 2014; Duan et al., 2017). The gene discussed is BDNF; the disease is brain ischemia.